|
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Capitalization1 |
12 790 | 17 134 | 15 564 | 20 043 | - | - |
| Entreprise Value (EV)1 |
26 394 | 25 973 | 22 839 | 28 160 | 28 024 | 28 251 |
| P/E ratio |
30,0x | 8,57x | -15,6x | -24,2x | 118x | 36,9x |
| Yield |
1,98% | 1,56% | 0,50% | 0,10% | 0,12% | 0,66% |
| Capitalization / Revenue |
1,09x | 1,33x | 3,02x | 2,27x | 1,70x | 1,55x |
| EV / Revenue |
2,24x | 2,01x | 4,42x | 3,19x | 2,37x | 2,18x |
| EV / EBITDA |
9,40x | 8,83x | -154x | 16,9x | 9,37x | 8,16x |
| Price to Book |
1,97x | 2,17x | 2,39x | 2,45x | 2,49x | 2,32x |
| Nbr of stocks (in thousands) |
527 198 | 514 984 | 493 939 | 490 536 | - | - |
| Reference price (USD) |
24,3 | 33,3 | 31,5 | 40,9 | 40,9 | 40,9 |
| Last update |
02/13/2019 | 02/12/2020 | 02/10/2021 | 06/11/2021 | 06/11/2021 | 06/11/2021 |
|
1 USD in Million Estimates
|
|
| Income Statement Evolution | |
|
|
|
| Annual Income Statement Data |
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net sales1 |
11 763 | 12 900 | 5 162 | 8 815 | 11 813 | 12 958 |
| EBITDA1 |
2 808 | 2 941 | -148 | 1 671 | 2 992 | 3 460 |
| Operating profit (EBIT)1 |
1 469 | 3 940 | -642 | -228 | 1 143 | 1 623 |
| Operating Margin |
12,5% | 30,5% | -12,4% | -2,58% | 9,67% | 12,5% |
| Pre-Tax Profit (EBT)1 |
634 | 2 847 | -1 511 | -829 | 412 | 862 |
| Net income1 |
467 | 2 049 | -1 033 | -833 | 109 | 539 |
| Net margin |
3,97% | 15,9% | -20,0% | -9,45% | 0,92% | 4,16% |
| EPS2 |
0,81 | 3,88 | -2,02 | -1,69 | 0,35 | 1,11 |
| Dividend per Share2 |
0,48 | 0,52 | 0,16 | 0,04 | 0,05 | 0,27 |
| Last update |
02/13/2019 | 02/12/2020 | 02/10/2021 | 06/11/2021 | 06/11/2021 | 06/11/2021 |
|
1 USD in Million 2 USD Estimates
|
|
|
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net Debt1 |
13 605 | 8 839 | 7 275 | 8 116 | 7 981 | 8 207 |
| Net Cash position1 |
- | - | - | - | - | - |
| Leverage (Debt / EBITDA) |
4,84x | 3,01x | -49,0x | 4,86x | 2,67x | 2,37x |
| Free Cash Flow1 |
236 | 1 071 | -1 764 | 469 | 1 007 | 1 216 |
| ROE (Net Profit / Equities) |
6,63% | 5,71% | -14,5% | -10,9% | 1,21% | 7,57% |
| Shareholders' equity1 |
7 045 | 35 912 | 7 116 | 7 607 | 9 017 | 7 115 |
| ROA (Net Profit / Asset) |
1,83% | 1,27% | -2,94% | -3,89% | 0,99% | 1,43% |
| Assets1 |
25 469 | 161 096 | 35 185 | 21 411 | 10 998 | 37 783 |
| Book Value Per Share2 |
12,3 | 15,4 | 13,2 | 16,7 | 16,4 | 17,6 |
| Cash Flow per Share2 |
3,13 | 3,43 | -3,02 | 1,30 | 2,93 | 3,80 |
| Capex1 |
1 487 | 739 | 271 | 379 | 528 | 622 |
| Capex / Sales |
12,6% | 5,73% | 5,24% | 4,29% | 4,47% | 4,80% |
| Last update |
02/13/2019 | 02/12/2020 | 02/10/2021 | 06/15/2021 | 06/15/2021 | 06/15/2021 |
|
1 USD in Million 2 USD Estimates
|
|
|
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
Exclusive: Why a U.S. hospital and oil company turned to facial recognition |
Capitalization (USD) 20 043 288 947 Net sales (USD) 5 162 082 000 Number of employees 54 000 Sales / Employee (USD) 95 594 Free-Float capitalization (USD) 17 095 840 344 Avg. Exchange 20 sessions (USD) 289 764 952 Average Daily Capital Traded 1,45%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
